This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Closing The Gap: TRICAST Debuts New Gaps In Care Analysis Product









MILWAUKEE, March 28, 2013 /PRNewswire/ -- TRICAST today announced the debut of its new Gaps in Care Analysis product, a set of analytic tools that enable any organization to gauge the effectiveness and performance of its wellness and preventive medicine programs.

What Are Gaps in Care?

Gaps in Care, sometimes referred to as Gaps in Coverage, are found by identifying the discrepancies between recommended best practice medical care, and the medical care that is actually provided to a patient. The gaps generally result from obstacles that prevent patients from implementing a physician's recommendations.

"TRICAST's Gaps in Care approach focuses on the key diseases linked to both high-cost medical programs and complex medical conditions. The value of the TRICAST analysis lies in our ability to proactively identify members who are receiving less than optimal treatment and then direct them to more active care management, or medical therapy management programs," says TRICAST President Greg Rucinski, R.Ph.

The Data Holds the Answers

TRICAST begins a Gaps in Care analysis by examining medical, pharmacy, and episodes of care data. After it ingests the data and uses its proprietary software tools to analyze these crucial components, TRICAST identifies and portrays diagnoses, procedure codes, and pharmaceutical treatments.

Disease State Profiles

Armed with this information, TRICAST can profile disease states and their associated costs by comparing the "best practice" treatment of a disease state to actual patterns of treatment. The reports that result define the gaps in care for these disease states:

  • Diabetes
  • Rheumatoid Arthritis
  • Migraines
  • Multiple Sclerosis
  • Coronary Artery Disease
  • Chronic Obstructive Pulmonary Disease with Asthma

Each disease state is profiled for total costs, as well as members identified with gaps in each one of those treatment modalities. Members having 10 or more gaps in each disease will be portrayed in the reporting system. TRICAST also defines and compares treatment gap patients with average costs per disease state to patients with no gaps in therapy to determine if the gap patients are increasing medical costs on a long-term basis.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 18,218.71 -67.03 -0.37%
S&P 500 2,130.88 +0.06 0.00%
NASDAQ 5,101.8630 +11.0690 0.22%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs